Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Biochip Market Research Report 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Biochip Industry
  • 1.7 COVID-19 Impact: Biochip Market Trends

    • 2 Global Biochip Quarterly Market Size Analysis

    • 2.1 Biochip Business Impact Assessment - COVID-19
      • 2.1.1 Global Biochip Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Biochip Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Biochip Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Biochip Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Biochip Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Biochip Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Biochip Market
    • 3.5 Key Manufacturers Biochip Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Biochip Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Microarrays
      • 1.4.2 Microfluidics
    • 4.2 By Type, Global Biochip Market Size, 2019-2021
      • 4.2.1 By Type, Global Biochip Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Biochip Price, 2020-2021

    5 Impact of Covid-19 on Biochip Segments, By Application

    • 5.1 Overview
      • 5.5.1 Biotechnology and Pharmaceutical Companies
      • 5.5.2 Hospitals and Diagnostics Centers
      • 5.5.3 Academic & Research Institutes
      • 5.5.4 Other End Users
    • 5.2 By Application, Global Biochip Market Size, 2019-2021
      • 5.2.1 By Application, Global Biochip Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Biochip Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Abbott Laboratories
      • 7.1.1 Abbott Laboratories Business Overview
      • 7.1.2 Abbott Laboratories Biochip Quarterly Production and Revenue, 2020
      • 7.1.3 Abbott Laboratories Biochip Product Introduction
      • 7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments
    • 7.2 PerkinElmer, Inc
      • 7.2.1 PerkinElmer, Inc Business Overview
      • 7.2.2 PerkinElmer, Inc Biochip Quarterly Production and Revenue, 2020
      • 7.2.3 PerkinElmer, Inc Biochip Product Introduction
      • 7.2.4 PerkinElmer, Inc Response to COVID-19 and Related Developments
    • 7.3 GE Healthcare
      • 7.3.1 GE Healthcare Business Overview
      • 7.3.2 GE Healthcare Biochip Quarterly Production and Revenue, 2020
      • 7.3.3 GE Healthcare Biochip Product Introduction
      • 7.3.4 GE Healthcare Response to COVID-19 and Related Developments
    • 7.4 Sigma-Aldrich Corporation
      • 7.4.1 Sigma-Aldrich Corporation Business Overview
      • 7.4.2 Sigma-Aldrich Corporation Biochip Quarterly Production and Revenue, 2020
      • 7.4.3 Sigma-Aldrich Corporation Biochip Product Introduction
      • 7.4.4 Sigma-Aldrich Corporation Response to COVID-19 and Related Developments
    • 7.5 Agilent Technologies, Inc
      • 7.5.1 Agilent Technologies, Inc Business Overview
      • 7.5.2 Agilent Technologies, Inc Biochip Quarterly Production and Revenue, 2020
      • 7.5.3 Agilent Technologies, Inc Biochip Product Introduction
      • 7.5.4 Agilent Technologies, Inc Response to COVID-19 and Related Developments
    • 7.6 Illumina, Inc.
      • 7.6.1 Illumina, Inc. Business Overview
      • 7.6.2 Illumina, Inc. Biochip Quarterly Production and Revenue, 2020
      • 7.6.3 Illumina, Inc. Biochip Product Introduction
      • 7.6.4 Illumina, Inc. Response to COVID-19 and Related Developments
    • 7.7 Bio-Rad Laboratories
      • 7.7.1 Bio-Rad Laboratories Business Overview
      • 7.7.2 Bio-Rad Laboratories Biochip Quarterly Production and Revenue, 2020
      • 7.7.3 Bio-Rad Laboratories Biochip Product Introduction
      • 7.7.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
    • 7.8 Fluidigm Corporation
      • 7.8.1 Fluidigm Corporation Business Overview
      • 7.8.2 Fluidigm Corporation Biochip Quarterly Production and Revenue, 2020
      • 7.8.3 Fluidigm Corporation Biochip Product Introduction
      • 7.8.4 Fluidigm Corporation Response to COVID-19 and Related Developments
    • 7.9 Thermo Fisher Scientific
      • 7.9.1 Thermo Fisher Scientific Business Overview
      • 7.9.2 Thermo Fisher Scientific Biochip Quarterly Production and Revenue, 2020
      • 7.9.3 Thermo Fisher Scientific Biochip Product Introduction
      • 7.9.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
    • 7.10 Merck Millipore
      • 7.10.1 Merck Millipore Business Overview
      • 7.10.2 Merck Millipore Biochip Quarterly Production and Revenue, 2020
      • 7.10.3 Merck Millipore Biochip Product Introduction
      • 7.10.4 Merck Millipore Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Biochip Supply Chain Analysis
      • 8.1.1 Biochip Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Biochip Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Biochip Distribution Channels
      • 8.2.2 Covid-19 Impact on Biochip Distribution Channels
      • 8.2.3 Biochip Distributors
    • 8.3 Biochip Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Biochip, including the following market information:
      Global Biochip Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Biochip Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Biochip Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Biochip Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Abbott Laboratories, PerkinElmer, Inc, GE Healthcare, Sigma-Aldrich Corporation, Agilent Technologies, Inc, Illumina, Inc., Bio-Rad Laboratories, Fluidigm Corporation, Thermo Fisher Scientific, Merck Millipore, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Microarrays
      Microfluidics

      Based on the Application:
      Biotechnology and Pharmaceutical Companies
      Hospitals and Diagnostics Centers
      Academic & Research Institutes
      Other End Users

      Buy now